Skip to main content

Table 3 Univariate and multivariate analyses of OS in 73 patients with LS-SCLC treated with early CCRT

From: Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities

Variable Univariate analysis Multivariate analysis
Relative risk 95% CI P value Relative risk 95% CI P value
Sex, male 1.77 0.79–4.71 0.1933  
Age ≥ 70 years 2.28 1.18–4.20 0.8471 0.88 0.39–1.84 0.7511
ECOG-PS = 0 0.86 0.45–1.67 0.6398 0.83 0.42–1.64 0.5840
Clinical stage III 0.95 0.45–2.23 0.8988 0.74 0.32–1.85 0.5002
Pre-existing ILAs 2.29 0.97–4.78 0.0338 2.51 1.02–5.62 0.0460
  1. OS, overall survival; LS-SCLC, limited-stage small-cell lung cancer; CCRT, concurrent chemoradiotherapy; CI, confidence interval; ECOG-PS, Eastern Cooperative Oncology Group performance status; ILA, interstitial lung abnormality